THE MEDICAL HOUSE AWARDED GRANT

The Medical House PLC (TMH) (AIM: MLH), the Sheffield based drug delivery and orthopaedic devices company, is expanding its premises and increasing its workforce following a £842,000 grant which has been jointly awarded by Selective Finance for Investment in England (SFI), which is managed by Yorkshire Forward, and Objective One. The total grant is comprised of £542,000 from SFI and £300,000 from Objective One.

The grant will support the development of both TMH’s orthopaedics division, Eurocut Ltd, and its drug delivery division, Medical House Products Ltd, based in Attercliffe, Sheffield.

Eurocut's expansion will boost manufacturing capacity through investment in new plant and equipment, the development of a range of disposable orthopaedic instruments and production of orthopaedic implants.

Medical House Products' expansion will support the growth of its drug delivery activities, including the commercialisation of its disposable AutoSafety Injector technology.

Executive Chairman, Ian Townsend, said: "The SFI grant represents a very signification recognition of The Medical House’s continued success in both orthopaedics and drug delivery. It will assist us in extending and diversifying our manufacturing facilities, so that we can capitalise on our growing reputation in both of these markets. This support will consolidate our position as a key employer within the Sheffield area and maintains our reputation within the medical devices industry."

Alex McWhirter, head of enterprise at Yorkshire Forward, said: "A key part of SFI is to invest in companies in Yorkshire and Humber which will create an improvement in the economy, raise productivity and improve employment skills. I am delighted The Medical House will benefit from this grant to boost its manufacturing capacity and continue its pioneering work to improve technology in the medical sector."

- ENDS -